E-LIB Suche - Ergebnisse für: DeJesus, E

1

Vesatolimod (GS-9620) is safe and pharmacodynamically activ..:

Riddler, S. ; Para, M. ; Benson, C....
Journal of Virus Eradication. 5 (2019) - p. 3 , 2019

Link: https://doi.org/10.1016/..

2

Switching to coformulated rilpivirine (RPV), emtricitabine ..:

Hagins, D ; Orkin, C ; Daar, ES...
HIV Medicine. 19 (2018) 10 - p. 724-733 , 2018

Link: https://doi.org/10.1111/..

3

Essai randomisé de bictégravir ou dolutégravir en associati..:

Sax, P. ; Dejesus, E. ; Ward, D....
Médecine et Maladies Infectieuses. 47 (2017) 4 - p. S139 , 2017

Link: https://doi.org/10.1016/..

4

The ASSURE study: HIV‐1 suppression is maintained with bone..:

Wohl, DA ; Bhatti, L ; Small, CB...
HIV Medicine. 17 (2015) 2 - p. 106-117 , 2015

Link: https://doi.org/10.1111/..

5

LP04 : A phase 3, open-label, single-arm study to evaluate ..:

Lawitz, E. ; Matusow, G. ; DeJesus, E....
Journal of Hepatology. 62 (2015) - p. S264-S265 , 2015

Link: https://doi.org/10.1016/..

6

O63 EFFICACY AND SAFETY OF THE ALL-ORAL REGIMEN, MK-5172/MK..:

Sulkowski, M. ; Mallolas, J. ; Pol, S....
Journal of Hepatology. 60 (2014) 1 - p. S26 , 2014

Link: https://doi.org/10.1016/..

7

O165 SIMEPREVIR PLUS SOFOSBUVIR WITH/WITHOUT RIBAVIRIN IN H..:

Lawitz, E. ; Ghalib, R. ; Rodriguez-Torres, M....
Journal of Hepatology. 60 (2014) 1 - p. S524 , 2014

Link: https://doi.org/10.1016/..

8

SWIFT: Prospective 48-Week Study to Evaluate Efficacy and S..:

Campo, R. ; DeJesus, E. ; Bredeek, U. F....
Clinical Infectious Diseases. 56 (2013) 11 - p. 1637-1645 , 2013

Link: https://doi.org/10.1093/..

9

SWIFT: Prospective 48-Week Study to Evaluate Efficacy and S..:

Campo, R. ; DeJesus, E. ; Bredeek, U. F....
Clinical Infectious Diseases. 56 (2013) 11 - p. 1637-1645 , 2013

Link: http://dx.doi.org/10.109..

10

A Single Amino Acid Substitution in the Group 1 Trypanosoma..:

DeJesus, E. ; Kieft, R. ; Albright, B....
PLoS Pathogens. 9 (2013) 4 - p. e1003317 , 2013

Link: https://doi.org/10.1371/..

11

SWIFT: Prospective 48-Week Study to Evaluate Efficacy and S..:

Campo, R. ; DeJesus, E. ; Bredeek, U. F....
Clinical Infectious Diseases. 56 (2013) 11 - p. 1637-1645 , 2013

Link: https://www.jstor.org/st..

12

A randomized pilot study of tenofovir/emtricitabine (TDF/FT..:

Cohen, C ; Green, J ; Olivet, H...
Journal of the International AIDS Society. 15 (2012) S4 - p. 1-1 , 2012

Link: https://doi.org/10.7448/..

13

Final 192‐week efficacy and safety of once‐daily darunavir/..:

Orkin, C ; DeJesus, E ; Khanlou, H...
HIV Medicine. 14 (2012) 1 - p. 49-59 , 2012

Link: https://doi.org/10.1111/..

14

1206 ABT-072 OR ABT-333 COMBINED WITH PEGYLATED INTERFERON/..:

Poordad, F. ; Lawitz, E. ; DeJesus, E....
Journal of Hepatology. 56 (2012) - p. S478 , 2012

Link: https://doi.org/10.1016/..

15

Indirect treatment comparison of efficacy, safety and resis..:

DeJesus, E ; Felix, J ; Vandewalle, B...
Journal of the International AIDS Society. 15 (2012) S4 - p. 1-1 , 2012

Link: https://doi.org/10.7448/..